Menu Search
Equities

Acadia Healthcare Company Inc

7RA:BER

Acadia Healthcare Company Inc

Actions
  • Price (EUR)38.20
  • Today's Change-0.600 / -1.55%
  • Shares traded--
  • 1 Year change-44.64%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Acadia Healthcare Company Inc had net income fall from a gain of 273.14m to a loss of 21.67m despite a 12.20% increase in revenues from 2.61bn to 2.93bn.
Gross margin--
Net profit margin9.31%
Operating margin15.40%
Return on assets5.18%
Return on equity9.77%
Return on investment6.10%
More ▼

Cash flow in USDView more

In 2023, Acadia Healthcare Company Inc did not generate a significant amount of cash. However, the company earned 462.34m from its operations for a Cash Flow Margin of 15.79%. In addition the company used 397.22m on investing activities and also paid 62.70m in financing cash flows.
Cash flow per share4.75
Price/Cash flow per share8.69
Book value per share33.04
Tangible book value per share7.56
More ▼

Balance sheet in USDView more

Acadia Healthcare Company Inc has a Debt to Total Capital ratio of 37.38%, a lower figure than the previous year's 49.77%.
Current ratio1.07
Quick ratio1.06
Total debt/total equity0.6194
Total debt/total capital0.3738
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		1,584.18
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.